Apyx Medical Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Apyx Medical Corp (APYX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 381.60 thousand shares for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2024-08-08
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2024-06-30 was 83.52K shares, a 73.78% increase year-over-year.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2024-03-31 was 298.08K shares, a 103.93% increase year-over-year.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-12-31 was 369.88K shares, a 279.52% increase year-over-year.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-09-30 was 84.32K shares, a 7.14% increase year-over-year.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 648.43K shares, a 156.13% increase from fiscal 2022.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 253.16K shares, a 24.27% increase from fiscal 2021.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2021 was 203.71K shares, a 30.20% decline from fiscal 2020.
- Apyx Medical Corp share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2020 was 291.85K shares, a 13.66% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2024-06-30 | 83.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 381.60K shares 10-Q · filed 2024-08-08 | 751.48K shares derived: sum of 3 quarters · filed 2024-08-08 | 835.80K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 298.08K shares 10-Q · filed 2024-05-09 | 667.96K shares derived: sum of 2 quarters · filed 2024-05-09 | 752.28K shares derived: sum of 3 quarters · filed 2024-05-09 | 800.34K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 369.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 454.20K shares derived: sum of 2 quarters · filed 2024-03-21 | 502.26K shares derived: sum of 3 quarters · filed 2024-03-21 | 648.43K shares 10-K · filed 2024-03-21 |
| 2023-09-30 | 84.32K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 132.38K shares derived: sum of 2 quarters · filed 2023-11-09 | 278.55K shares 10-Q · filed 2023-11-09 | 376.01K shares derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-06-30 | 48.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | 194.22K shares 10-Q · filed 2023-08-11 | 291.69K shares derived: sum of 3 quarters · filed 2024-03-21 | 370.39K shares derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-03-31 | 146.16K shares 10-Q · filed 2023-05-11 | 243.63K shares derived: sum of 2 quarters · filed 2024-03-21 | 322.32K shares derived: sum of 3 quarters · filed 2024-03-21 | 384.80K shares derived: sum of 4 quarters · filed 2024-03-21 |
| 2022-12-31 | 97.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 176.16K shares derived: sum of 2 quarters · filed 2024-03-21 | 238.63K shares derived: sum of 3 quarters · filed 2024-03-21 | 253.16K shares 10-K · filed 2024-03-21 |
| 2022-09-30 | 78.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 141.17K shares derived: sum of 2 quarters · filed 2022-11-10 | 155.70K shares 10-Q · filed 2022-11-10 | 168.62K shares derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-06-30 | 62.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 77.00K shares 10-Q · filed 2022-08-11 | 89.92K shares derived: sum of 3 quarters · filed 2023-03-16 | 182.07K shares derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-03-31 | 14.53K shares 10-Q · filed 2022-05-12 | 27.44K shares derived: sum of 2 quarters · filed 2023-03-16 | 119.60K shares derived: sum of 3 quarters · filed 2023-03-16 | 181.84K shares derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-12-31 | 12.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 105.08K shares derived: sum of 2 quarters · filed 2023-03-16 | 167.31K shares derived: sum of 3 quarters · filed 2023-03-16 | 203.71K shares 10-K · filed 2023-03-16 |
| 2021-09-30 | 92.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 154.39K shares derived: sum of 2 quarters · filed 2021-11-12 | 190.79K shares 10-Q · filed 2021-11-12 | 248.04K shares derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-06-30 | 62.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 98.64K shares 10-Q · filed 2021-08-12 | 155.88K shares derived: sum of 3 quarters · filed 2022-03-17 | 179.05K shares derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-03-31 | 36.40K shares 10-Q · filed 2021-05-12 | 93.65K shares derived: sum of 2 quarters · filed 2022-03-17 | 116.82K shares derived: sum of 3 quarters · filed 2022-03-17 | 185.95K shares derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-12-31 | 57.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 80.42K shares derived: sum of 2 quarters · filed 2022-03-17 | 149.55K shares derived: sum of 3 quarters · filed 2022-03-17 | 291.85K shares 10-K · filed 2022-03-17 |
| 2020-09-30 | 23.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 92.30K shares derived: sum of 2 quarters · filed 2020-11-09 | 234.60K shares 10-Q · filed 2020-11-09 | 307.88K shares derived: sum of 4 quarters · filed 2021-03-31 |
| 2020-06-30 | 69.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 211.43K shares 10-Q · filed 2020-08-10 | 284.72K shares derived: sum of 3 quarters · filed 2021-03-31 | 417.72K shares derived: sum of 4 quarters · filed 2021-03-31 |
| 2020-03-31 | 142.30K shares 10-Q · filed 2020-05-11 | 215.59K shares derived: sum of 2 quarters · filed 2021-03-31 | 348.58K shares derived: sum of 3 quarters · filed 2021-03-31 | 388.58K shares derived: sum of 4 quarters · filed 2021-03-31 |
| 2019-12-31 | 73.28K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 206.28K shares derived: sum of 2 quarters · filed 2021-03-31 | 246.28K shares derived: sum of 3 quarters · filed 2021-03-31 | 256.79K shares 10-K · filed 2021-03-31 |
| 2019-09-30 | 133.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-15 | 173.00K shares derived: sum of 2 quarters · filed 2019-11-15 | 183.50K shares 10-Q · filed 2019-11-15 | 183.50K shares derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-06-30 | 40.00K shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2019-08-07 | 50.50K shares 10-Q · filed 2019-08-07 | 50.50K shares derived: sum of 3 quarters · filed 2020-05-08 | 218.84K shares derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-03-31 | 10.50K shares 10-Q/A · filed 2020-05-08 | 10.50K shares derived: sum of 2 quarters · filed 2020-05-08 | 178.84K shares derived: sum of 3 quarters · filed 2020-05-08 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2020-03-31 | 168.34K shares derived: sum of 2 quarters · filed 2020-05-08 | 225.84K shares 10-K · filed 2020-03-31 | |
| 2018-09-30 | 168.34K shares derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-05-08 | 225.84K shares 10-Q/A · filed 2020-05-08 | ||
| 2018-06-30 | 57.50K shares 10-Q · filed 2018-08-01 | |||
| 2017-12-31 | 246.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | 239.50K shares derived: sum of 2 quarters · filed 2020-03-31 | 352.25K shares derived: sum of 3 quarters · filed 2020-03-31 | 443.30K shares 10-K · filed 2020-03-31 |
| 2017-09-30 | -7.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | 105.75K shares derived: sum of 2 quarters · filed 2017-11-03 | 196.80K shares 10-Q · filed 2017-11-03 | 350.62K shares derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | 112.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 203.80K shares 10-Q · filed 2017-08-03 | 357.62K shares derived: sum of 3 quarters · filed 2019-03-14 | |
| 2017-03-31 | 91.05K shares 10-Q · filed 2017-05-15 | 244.87K shares derived: sum of 2 quarters · filed 2019-03-14 | ||
| 2016-12-31 | 153.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 153.75K shares 10-K · filed 2019-03-14 | ||
| 2016-09-30 | -68.00 shares 10-Q · filed 2016-10-27 | |||
| 2015-12-31 | 466.16K shares 10-K · filed 2017-03-10 | |||
| 2012-12-31 | 4.88K shares 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |